Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients
This study demonstrates the ability of a protein-based signature to risk-stratify prostate cancer patients with Gleason grade groups 2 and 3 and predict the risk of biochemical recurrence.
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Life Science Alliance LLC
2026-02-01
|
| Edice: | Life Science Alliance |
| On-line přístup: | https://www.life-science-alliance.org/lookup/doi/10.26508/lsa.202503547 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
